Echocardiographic Standards and Sub-Saharian Africans (SSA) Migrants' in New Aquitaine Region

NCT ID: NCT04865068

Last Updated: 2021-04-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-06-01

Study Completion Date

2022-09-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Standards Echocardiographic have been defined mainly on caucasian or Asian populations. In the EchoNoRMAL study the criteria for African populations were based solely on data from 198 subjects. This study suggests the presence of different standards depending on the ethnic origin of the subjects. The aims of this study is to describe the proportion of subjects reclassified (normal-pathological) according to the use of echocardiographic norm differences showed in TAHES population (Sub Saharian Africans) with those routinely used

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Sub-Saharian Africans populations seem to be more vulnerable in the field of health in general and in cardiovascular pathologies in particular.

* The echocardiographic standards were mainly defined for Caucasian or Asian populations (EchoNoRMAL col. 2014 and 2015). In the EchoNoRMAL study, the criteria for the African populations were based on a reduced workforce (data from 198 subjects).
* This study suggests the presence of different standards depending on the ethnic origin of the subjects. The authors noted that the establishment of references according to the ethnic origin of the subjects is necessary and highlighted the need for additional study for the underrepresented groups, in particular those including subjects of African origin.

The need for different ECG standards in African subjects, was confirmed in a study in the general African population (TAHES), represents 16% of immigrants in 2015 (INSEE According to reports from the health insurance funds, the migrant population,

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diagnosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

African migrant's population located in la region New Aquitaine.

Echocardiography norms will be harvested data on SSA participants located in la region New Aquitaine, France

Group Type EXPERIMENTAL

Echocardiography measures on SSA participants

Intervention Type DIAGNOSTIC_TEST

Upon SSA Subject is admitted to the hospital for an echocardiography,

* Information about this study process,
* Participants will receive an information note ;
* Administration of a medical history questionnaire, collection of cardiovascular risk factors, weight toe (all of which are routinely collected before an echocardiographic examination is performed);
* Performing and recording the echocardiographic examination according to routine protocol
* delivery of the results according to the usual management;
* deferred analysis of the recordings on workstation with classification of the data (normal-pathological) according to the different standards

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Echocardiography measures on SSA participants

Upon SSA Subject is admitted to the hospital for an echocardiography,

* Information about this study process,
* Participants will receive an information note ;
* Administration of a medical history questionnaire, collection of cardiovascular risk factors, weight toe (all of which are routinely collected before an echocardiographic examination is performed);
* Performing and recording the echocardiographic examination according to routine protocol
* delivery of the results according to the usual management;
* deferred analysis of the recordings on workstation with classification of the data (normal-pathological) according to the different standards

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- SSA Major Subjects (first generation or from or from first generation parents) admitted to the hospital for an echocardiography

Exclusion Criteria

* Participation refusal;
* Any acute heart disease (endocarditis, myocarditis, coronary syndrome);
* Valvulopathy justifying an intervention;
* Diseases of overload.
* Any acute heart disease (endocarditis, myocarditis, coronary syndrome);
* Valvulopathy justifying an intervention;
* Diseases of overload.
* Both participant and accompanying person unable to understand the information note written in French and in English
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Bordeaux

OTHER

Sponsor Role collaborator

University Hospital, Limoges

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Philippe Lacroix, Professor

Role: PRINCIPAL_INVESTIGATOR

0033555056391

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Explorations fonctionnelles vasculaires et angiologie (Hôpital Dupuytren)

Limoges, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Philippe Lacroix, Professor

Role: CONTACT

0033555056391

Arnaud Garcia, PhD

Role: CONTACT

0033555087148

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

87RI20_0020 /NEMANA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Analysis of Cardiac Biomarker Racial Discrepancies
NCT05224557 ENROLLING_BY_INVITATION
Genetics of Ventriculo-arterial Discordance
NCT05330338 ACTIVE_NOT_RECRUITING NA